Opus Genetics (IRD) Cash from Investing Activities (2010 - 2024)

Opus Genetics (IRD) has 13 years of Cash from Investing Activities data on file, last reported at $1.2 million in Q4 2024.

• On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $1.2 million in Q4 2024; TTM through Sep 2025 was $1.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 million, changed N/A from the prior year.
• Cash from Investing Activities for Q4 2024 stood at $1.2 million, up from -$100000.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for IRD reached as high as $1.2 million in Q4 2024 and fell as low as -$100000.0 in Q4 2021.
• Historically, Cash from Investing Activities has averaged $549666.7 across 3 years, with a median of $539000.0 in 2020.
• Across the five-year window, Cash from Investing Activities jumped 536.26% in 2020 and plunged 118.55% in 2021, its largest moves.
• Year by year, Cash from Investing Activities stood at $539000.0 in 2020, then plunged by 118.55% to -$100000.0 in 2021, then jumped by 1310.0% to $1.2 million in 2024.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $1.2 million in Q4 2024, -$100000.0 in Q4 2021, and $539000.0 in Q4 2020.